Comment re

"Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "aberrant crypt foci in the adenoma prevention with celecoxib trial"

Michael P Lance, Stanley R. Hamilton

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)216
Number of pages1
JournalCancer Prevention Research
Volume1
Issue number3
DOIs
StatePublished - Aug 2008

Fingerprint

Celecoxib
Aberrant Crypt Foci
Adenoma
Biomarkers

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{b98168db188b4d1fa55f970e7787f50d,
title = "Comment re: {"}Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention{"} and {"}aberrant crypt foci in the adenoma prevention with celecoxib trial{"}",
author = "Lance, {Michael P} and Hamilton, {Stanley R.}",
year = "2008",
month = "8",
doi = "10.1158/1940-6207.CAPR-08-0132",
language = "English (US)",
volume = "1",
pages = "216",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Comment re

T2 - "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "aberrant crypt foci in the adenoma prevention with celecoxib trial"

AU - Lance, Michael P

AU - Hamilton, Stanley R.

PY - 2008/8

Y1 - 2008/8

UR - http://www.scopus.com/inward/record.url?scp=58349107214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58349107214&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-08-0132

DO - 10.1158/1940-6207.CAPR-08-0132

M3 - Article

VL - 1

SP - 216

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 3

ER -